ATE198478T1 - Verfahren zur herstellung eines tetrazolderivates in zwei kristallinen formen und eine neue kristallform dieses derivates - Google Patents

Verfahren zur herstellung eines tetrazolderivates in zwei kristallinen formen und eine neue kristallform dieses derivates

Info

Publication number
ATE198478T1
ATE198478T1 AT95402322T AT95402322T ATE198478T1 AT E198478 T1 ATE198478 T1 AT E198478T1 AT 95402322 T AT95402322 T AT 95402322T AT 95402322 T AT95402322 T AT 95402322T AT E198478 T1 ATE198478 T1 AT E198478T1
Authority
AT
Austria
Prior art keywords
derivative
water
ray diffraction
diffraction pattern
producing
Prior art date
Application number
AT95402322T
Other languages
English (en)
Inventor
Antoine Caron
Dominique Chantreux
Colette Bouloumie
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE198478T1 publication Critical patent/ATE198478T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
AT95402322T 1994-10-19 1995-10-18 Verfahren zur herstellung eines tetrazolderivates in zwei kristallinen formen und eine neue kristallform dieses derivates ATE198478T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412459A FR2725987B1 (fr) 1994-10-19 1994-10-19 Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive

Publications (1)

Publication Number Publication Date
ATE198478T1 true ATE198478T1 (de) 2001-01-15

Family

ID=9467986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95402322T ATE198478T1 (de) 1994-10-19 1995-10-18 Verfahren zur herstellung eines tetrazolderivates in zwei kristallinen formen und eine neue kristallform dieses derivates

Country Status (26)

Country Link
US (1) US5629331A (de)
EP (1) EP0708103B1 (de)
JP (1) JP3366786B2 (de)
KR (1) KR100251222B1 (de)
CN (1) CN1061656C (de)
AT (1) ATE198478T1 (de)
AU (1) AU698041B2 (de)
CA (1) CA2160725C (de)
CY (1) CY2277B1 (de)
CZ (2) CZ288629B6 (de)
DE (1) DE69519788T2 (de)
DK (1) DK0708103T3 (de)
ES (1) ES2155115T3 (de)
FI (1) FI114156B (de)
FR (1) FR2725987B1 (de)
GR (1) GR3035503T3 (de)
HU (1) HU226461B1 (de)
IL (1) IL115688A (de)
NO (1) NO307516B1 (de)
NZ (1) NZ280293A (de)
PL (1) PL184193B1 (de)
PT (1) PT708103E (de)
RU (1) RU2144536C1 (de)
SI (1) SI0708103T1 (de)
TW (1) TW357147B (de)
ZA (1) ZA958850B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
HUP0104634A3 (en) 1998-07-06 2002-11-28 Bristol Myers Squibb Co Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AR032758A1 (es) * 2000-07-19 2003-11-26 Novartis Ag Sales valsartan, un proceso para su fabricacion, composiciones farmaceuticas y el uso de dichas sales para la preparacion de medicamentos
US20050176793A1 (en) * 2001-12-10 2005-08-11 Reddy Reguri B. Amorphous form of 2-n-butyl-3-((2-(1h-tetrazol-5-yl)([1,1'-biphenyl)-4-yl)methyl)-1, 3-diazaspiro(4,4')non-1-en-4-one
CN1668612A (zh) * 2002-07-16 2005-09-14 特瓦制药工业有限公司 厄贝沙坦的新合成方法
SI1509517T1 (sl) * 2003-01-16 2008-10-31 Teva Pharma Nova sinteza irbesartana
WO2004072064A1 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol[4,4]-non-ene-4-one
WO2004089938A1 (en) * 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of irbesartan
PL379420A1 (pl) * 2003-07-31 2006-09-04 Nicox S.A. Pochodne blokerów receptora angiotensyny II
TW200526638A (en) * 2003-10-22 2005-08-16 Smithkline Beecham Corp 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
WO2006001026A1 (en) * 2004-06-23 2006-01-05 Hetero Drugs Limited Irbesartan polymorphs
SI21849A (sl) * 2004-07-29 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava hidrokloridnih soli tetrazolskega derivata
TWI346108B (en) 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
US20090208573A1 (en) * 2004-11-11 2009-08-20 Lek Pharmaceuticals D.D Novel polymorph form of irbesartan
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
WO2007013101A1 (en) * 2005-07-27 2007-02-01 Jubilant Organosys Limited PROCESS FOR PRODUCING 2-(N-BUTYL)-3-[[2'-(TETRAZOL-5-YL)BIPHENYL- 4-YL]METHYL]-l,3-DIAZASPIRO[4.4] NON-1-EN-4-ONE
PT1806130E (pt) 2006-01-09 2010-05-11 Krka D D Novo Mesto Composições farmacêuticas sólidas que compreendem irbesartan
WO2008041957A1 (en) * 2006-10-03 2008-04-10 Ulkar Kimya Sanayi Ve Ticaret As Method for producing pure crystalline form of 2-n-butyl-3-((2-(1h-tetrazole-5-yl) (1,1'-biphenyl)-4-methyl)-1,3-diazapspiro (4,4') non -1- en-4-one
EP1918288A1 (de) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited Neues und verbessertes Verfahren für die Zubereitung von Irbesartan, einem Angiotensin-II Rezeptorantagonisten für die Behandlung von Bluthochdruck
PT2065035E (pt) * 2007-11-28 2010-10-04 Lesvi Laboratorios Sl Formulações farmacêuticas contendo irbesartan
WO2009072137A2 (en) * 2007-12-07 2009-06-11 Hetero Drugs Limited Process for pure irbesartan
KR101009383B1 (ko) * 2008-04-30 2011-01-19 켐젠주식회사 고순도의2-부틸-3-[[2'-(1에이취-테트라졸-5-일)[1,1'-비페닐]-4-일]메틸]-1,3-디아자스피로[4.4]논-1-엔-4-온 화합물의제조방법
EP2417110B1 (de) * 2009-04-08 2014-05-07 CTX Life Sciences Pvt. Ltd. Eintopfverfahren zur herstellung von 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'- biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4] non-1-en-4-on (irbesartan)
AR078107A1 (es) * 2009-08-31 2011-10-12 Sanofi Aventis Uso de irbesartan para la preparacion de un medicamento para la prevencion de la hospitalizacion por insuficiencia cardiaca
US8080670B2 (en) 2010-05-04 2011-12-20 Divi's Laboratories, Ltd. Process for the preparation of irbesartan
FR2977253B1 (fr) 2011-06-30 2013-08-09 Centre Nat Rech Scient Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
MX2024003962A (es) 2021-10-01 2024-06-28 Sanofi Sa Procedimiento para preparar compuestos activos tipo sartanes que tienen un anillo de tetrazol.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
JP2697919B2 (ja) * 1989-09-29 1998-01-19 キヤノン株式会社 信号内挿回路及び該回路を備えた変位測定装置
US5104891A (en) * 1989-12-11 1992-04-14 G. D. Searle & Co. Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
TW201738B (de) * 1990-03-20 1993-03-11 Sanofi Co
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds
FR2673427B1 (fr) * 1991-03-01 1993-06-18 Sanofi Elf Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
CN1128261A (zh) 1996-08-07
DK0708103T3 (da) 2001-04-23
DE69519788T2 (de) 2001-08-30
PL311012A1 (en) 1996-04-29
DE69519788D1 (de) 2001-02-08
FR2725987A1 (fr) 1996-04-26
NO954154L (no) 1996-04-22
AU3433595A (en) 1996-05-02
CZ288629B6 (cs) 2001-08-15
CA2160725C (en) 2001-12-18
HK1005135A1 (en) 1998-12-24
CA2160725A1 (en) 1996-04-20
NO954154D0 (no) 1995-10-18
NZ280293A (en) 1997-10-24
GR3035503T3 (en) 2001-06-29
HU226461B1 (en) 2008-12-29
EP0708103A1 (de) 1996-04-24
FI954992L (fi) 1996-04-20
HUT73179A (en) 1996-06-28
FR2725987B1 (fr) 1997-01-10
IL115688A0 (en) 1996-01-19
JPH08208642A (ja) 1996-08-13
ZA958850B (en) 1996-05-27
KR100251222B1 (ko) 2000-05-01
HU9503016D0 (en) 1995-12-28
CZ271095A3 (en) 1996-05-15
FI114156B (fi) 2004-08-31
ES2155115T3 (es) 2001-05-01
EP0708103B1 (de) 2001-01-03
US5629331A (en) 1997-05-13
CN1061656C (zh) 2001-02-07
KR960014122A (ko) 1996-05-22
RU2144536C1 (ru) 2000-01-20
CY2277B1 (en) 2003-07-04
FI954992A0 (fi) 1995-10-19
NO307516B1 (no) 2000-04-17
JP3366786B2 (ja) 2003-01-14
SI0708103T1 (en) 2001-04-30
PT708103E (pt) 2001-06-29
TW357147B (en) 1999-05-01
IL115688A (en) 1999-09-22
AU698041B2 (en) 1998-10-22
CZ288624B6 (cs) 2001-08-15
PL184193B1 (pl) 2002-09-30

Similar Documents

Publication Publication Date Title
ATE198478T1 (de) Verfahren zur herstellung eines tetrazolderivates in zwei kristallinen formen und eine neue kristallform dieses derivates
ATE207970T1 (de) Verfahren zur rückgewinnung von xylose aus lösungen
DE69530104D1 (de) Neue benzylpyrimidine
RU95118109A (ru) Способ получения производного тетразола, способ получения формы b производного тетразола, форма b производного тетразола и фармацевтическая композиция на основе производного тетразола формы b
ATE556032T1 (de) Blattförmiges kaliumtitanat, verfharen zu dessen herstellung und reibmaterial
DK0889874T3 (da) 7-Amino-2-heptenoater og anvendelse deraf ved fremstillingen af methylphenidat
NO20022777D0 (no) Overflateaktive blandinger for opprensing av brönn
ATE400617T1 (de) Gamma-kristallmodifikation von c.i. pigment yellow 191 und verfahren zu ihrer herstellung
DE69610374D1 (de) Verfahren zur Herstellung einer Kristallinen Sonderform von Zilpaterolhydrochlorid, und benutze Zwischenprodukte
ATE116285T1 (de) Verfahren zur herstellung von kristallen eines salzes von sauerer aminosäure und basischer aminosäure.
EP1702959A3 (de) Oberflächenbehandelte organische Pigmente
DE69322568D1 (de) Verfahren und Zusammensetzung zum Entfernen von Sauerstoff
EP1135376B1 (de) Verfahren zur herstellung von cyclen
EP1555262A4 (de) VERFAHREN ZUR KRISTALLAUSFûLLUNG
ATE173002T1 (de) Verfahren zur entklebung von sowohl wasserverdünnbaren als auch lösungsmittel enthaltenden lacken
EP0398230A3 (de) Antivirale, gut wasserlösliche, stabile, kristalline Salze von 2',3'-Dideoxyinosinmonohydrat, 2',3'-Dideoxy-2',3'-didehydrothymidinmonohydrat und 2',3'-Dideoxy-2'-fluoroinosinhemihydrat
大江真道 et al. Changes in the characteristic of dry matter production of Japonica type paddy rice (Oryza sativa L.) due to the Deep-water Treatment
Philips et al. Surface supplies help save nature in the Netherlands
FR2742439B1 (fr) Procede de preparation de la 4'-demethylepipodophyllotoxine a partir de la podophyllotoxine
CA2081135A1 (en) Method for precipitating an organic resin from an alkaline solution thereof
JP2003523966A5 (de)
RU99113400A (ru) Способ очистки сточных вод
DE59001784D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
SAWAI et al. A Study on the Control of the Estuary Sedimentation Using a Tidal Reservoir
ES2178593A1 (es) Procedimiento de secado de fangos de depuradora y coagulante-floculante para la realizacion del mismo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification